Two days after Brazil's government declared a contract with Oxford University and pharmaceutical company AstraZeneca to get up to 100 million doses of a promising coronavirus vaccine, a manager of the company stated the document was actually a letter of purpose and there continue to be crucial items to be negotiated.

AstraZeneca manager Jorge Mazzei told reporters on Monday that if the vaccine works that he considers the hard-hit South American nation will get it at the end of the year. However he has just had the very first call with neighborhood partners Fiocruz and will start working on a contract on Tuesday.

Brazil counts nearly 58,000 dead by COVID-19, and over 1.2 million cases of this disease.

It's nearly impossible that this contract is not signed, Mazzei stated. It required two to three weeks for the letter of intent to be signed. Our objective is that contract is signed as speedily as possible." On Saturday, authorities of Brazil's health ministry said the state will pay USD 127 million for substance to produce initial 30.4 million doses in two batches in December and January. They included the inoculation efforts would start quickly in the event the vaccine is certified to be safe and effective.

Ever since last week the vaccine has been tested on more than 5,000 Brazilians of their healthcare sector.

The Brazilian authorities said the total price will be for 100 million doses for a country of roughly 210 million taxpayers. After the first batch, 70 million vaccines created by local vaccine maker Fiocruz, however, the terms for that step are yet to be defined.

I trust there is a plan (of the Brazilian government) on how best to vaccinate all the folks, AstraZeneca's director added. Mazzei said that there are key elements to be negotiated, including the area of the transfer of technologies and the next buy of 70 million dosages. He said other countries already have deals at this point, however, says Brazil is in exactly the exact same tide of the first nations to find the shot.

The Brazilian government said the first to get the Oxford shots would be high-risk groups such as the elderly, people who have comorbidities and health and security professionals.

Ray President Jair Bolsonaro was criticized for downplaying his administration's response to the outbreak, comparing the disease to a tiny flu.